@thunderhead1
My answer to your question is: No, I'm not interested in this cigar-butt.
Please note that I haven't done any in-depth analysis of RCG for a long time. The last time I seriously looked into it was back in 2009 and since then I have been following it on a superficial level.
But I will still give you my reasons (which might be incorrect):
- Amazon. Personally I believe that RCG's future won't be enhanced by the arrival of this online giant.
- Sale of significant amount of shares by original backers of RCG last year at $1.50 had again proved that insiders know best!
- Current management structure of having 2 Co-CEO is not a good idea. I believe it's only a matter of time before a clash of ego ala Vocus happens here. I might be wrong on this though!
- Bad news usually is not isolated. There are people who believe that bad news usually comes in three. In RCG's case, it's already on two.
The first downgrade on 24/02/17 from FY17 EBITDA guidance of $90m (which was affirmed in 2016 AGM) to a guidance of $85-88m.
The second downgrade on 01/05/17 brought the guidance for FY17 EBITDA to $74-80m.
With the H1 2017 EBITDA coming in at $42.9m, this means that the rate of decline in the second half is accelerating.
- All of these are happening while the operating lease commitment is increasing from $106m in FY2015 to $168m in FY2016, and to $292m in HY2017.
- I also believe that the management and directors are overpaid and that they look after themselves first and minority shareholders second.
Cheers
- Forums
- ASX - By Stock
- Where to from here?
@thunderhead1 My answer to your question is: No, I'm not...
-
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AX1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.45 |
Change
0.110(4.70%) |
Mkt cap ! $1.386B |
Open | High | Low | Value | Volume |
$2.35 | $2.46 | $2.34 | $3.609M | 1.489M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 501 | $2.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.46 | 53949 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 501 | 2.440 |
6 | 22062 | 2.430 |
3 | 7323 | 2.420 |
3 | 17031 | 2.410 |
2 | 7083 | 2.400 |
Price($) | Vol. | No. |
---|---|---|
2.460 | 53949 | 6 |
2.470 | 64492 | 7 |
2.480 | 25942 | 4 |
2.490 | 76270 | 8 |
2.500 | 64594 | 17 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AX1 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online